ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991